ARTICLE | Finance
Histogenics regeneration
Sofinnova leads recap deal for regenerative medicine play Histogenics
August 6, 2012 7:00 AM UTC
Sofinnova Ventures made its first regenerative medicine investment last month when it led a $49 million round that recapped Histogenics Corp.
New investors Split Rock Partners; BioMed Ventures; and FinTech GIMV Fund participated along with existing investors ProChon Holdings; Altima Partners; Foundation Medical Partners; Inflection Point Capital; and Boston Millennia Partners. Boston Equity Advisors was the placement agent...